The diversity of circulating neutrophils in cancer

Immunobiology

Volumn 222, Issue 1, 2017, Pages 82-88

  Mishalian, Inbal ^a   Granot, Zvi ^b   Fridlender, Zvi G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cancer; Neutrophils; Tumor immunology

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD33 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; BIOLOGICAL MARKER;

BONE MARROW CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRUCTURE; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CIRCULATING TUMOR CELL; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HUMAN; LYMPHOCYTE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR INTERACTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TUMOR IMMUNITY; ANIMAL; BLOOD; CYTOLOGY; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE COUNT; METABOLISM; MORTALITY; MYELOID-DERIVED SUPPRESSOR CELL; NEOPLASM; OXIDATION REDUCTION REACTION; PHENOTYPE; PROGNOSIS; TUMOR MICROENVIRONMENT;

ANIMALS; BIOMARKERS; HUMANS; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE COUNT; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASMS; NEUTROPHILS; OXIDATION-REDUCTION; PHENOTYPE; PROGNOSIS; TUMOR MICROENVIRONMENT;

EID: 84957894723     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2016.02.001     Document Type: Review

References (69)

1. Almand, B., Clark, J.I., Nikitina, E., van Beynen, J., English, N.R., Knight, S.C., Carbone, D.P., Gabrilovich, D.I., Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol., 166, 2001, 678.
2. Amulic, B., Cazalet, C., Hayes, G.L., Metzler, K.D., Zychlinsky, A., Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol., 30, 2012, 459.
3. Andzinski, L., Wu, C.F., Lienenklaus, S., Kroger, A., Weiss, S., Jablonska, J., Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-beta. Int. J. Cancer, 136, 2014, 572.
4. Borregaard, N., Sorensen, O.E., Theilgaard-Monch, K., Neutrophil granules: a library of innate immunity proteins. Trends Immunol., 28, 2007, 340.
5. Borregaard, N., Neutrophils, from marrow to microbes. Immunity, 33, 2010, 657.
6. Boyum, A., Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest. Suppl., 97, 1968, 77.
7. Brandau, S., Trellakis, S., Bruderek, K., Schmaltz, D., Steller, G., Elian, M., Suttmann, H., Schenck, M., Welling, J., Zabel, P., Lang, S., Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol., 89, 2011, 311.
8. Brandau, S., Moses, K., Lang, S., The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?. Semin. Cancer Biol., 23, 2013, 171.
9. Cerutti, A., Puga, I., Magri, G., The B cell helper side of neutrophils. J. Leukoc. Biol., 94, 2013, 677.
10. Choi, J., Suh, B., Ahn, Y.O., Kim, T.M., Lee, J.O., Lee, S.H., Heo, D.S., CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol., 33, 2012, 121.
11. Cloke, T., Munder, M., Taylor, G., Muller, I., Kropf, P., Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS One, 7, 2012, e48939.
12. Colombo, M.P., Lombardi, L., Stoppacciaro, A., Melani, C., Parenza, M., Bottazzi, B., Parmiani, G., Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J. Immunol., 149, 1992, 113.
13. Daley, J.M., Thomay, A.A., Connolly, M.D., Reichner, J.S., Albina, J.E., Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol., 83, 2008, 64.
14. Damuzzo, V., Pinton, L., Desantis, G., Solito, S., Marigo, I., Bronte, V., Mandruzzato, S., Complexity and challenges in defining myeloid-derived suppressor cells. Cytometry B Clin. Cytom. 88:2 (2015), 77–91.
15. De Larco, J.E., Wuertz, B.R., Furcht, L.T., The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin. Cancer Res., 10, 2004, 4895.
16. De Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., Cerundolo, V., Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol., 11, 2010, 1039.
17. Denny, M.F., Yalavarthi, S., Zhao, W., Thacker, S.G., Anderson, M., Sandy, A.R., McCune, W.J., Kaplan, M.J., A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol., 184, 2010, 3284.
18. Di Carlo, E., Forni, G., Lollini, P., Colombo, M.P., Modesti, A., Musiani, P., The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood, 97, 2001, 339.
19. Donskov, F., Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol., 23, 2013, 200.
20. Dumitru, C.A., Moses, K., Trellakis, S., Lang, S., Brandau, S., Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother., 61, 2012, 1155.
21. Elghetany, M.T., Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis., 28, 2002, 260.
22. Eruslanov, E.B., Bhojnagarwala, P.S., Quatromoni, J.G., Stephen, T.L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W.W., Conejo-Garcia, J.R., Feldman, M., Albelda, S.M., Singhal, S., Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J. Clin. Invest., 124, 2014, 5466.
23. Fridlender, Z.G., Albelda, S.M., Tumor-associated neutrophils: friend or foe?. Carcinogenesis, 33, 2012, 949.
24. Fridlender, Z.G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G.S., Albelda, S.M., Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell, 16, 2009, 183.
25. Fridlender, Z.G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G.S., Albelda, S.M., Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One, 7, 2012, e31524.
26. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol., 9, 2009, 162.
27. Gabrilovich, D.I., Velders, M.P., Sotomayor, E.M., Kast, W.M., Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol., 166, 2001, 5398.
28. Granot, Z., Henke, E., Comen, E.A., King, T.A., Norton, L., Benezra, R., Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell, 20, 2011, 300.
29. Greifenberg, V., Ribechini, E., Rossner, S., Lutz, M.B., Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol., 39, 2009, 2865.
30. Greten, T.F., Manns, M.P., Korangy, F., Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol., 11, 2011, 802.
31. Guedez, L., Jensen-Taubman, S., Bourboulia, D., Kwityn, C.J., Wei, B., Caterina, J., Stetler-Stevenson, W.G., TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis. J. Immunother., 35, 2012, 502.
32. Guthrie, G.J., Charles, K.A., Roxburgh, C.S., Horgan, P.G., McMillan, D.C., Clarke, S.J., The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit. Rev. Oncol. Hematol., 88, 2013, 218.
33. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell, 144, 2011, 646.
34. Heifets, L., Centennial of Metchnikoff's discovery. J. Reticuloendothel. Soc., 31, 1982, 381.
35. Hicks, A.M., Riedlinger, G., Willingham, M.C., Alexander-Miller, M.A., Von Kap-Herr, C., Pettenati, M.J., Sanders, A.M., Weir, H.M., Du, W., Kim, J., Simpson, A.J., Old, L.J., Cui, Z., Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc. Natl. Acad. Sci. U. S. A., 103, 2006, 7753.
36. Hock, B.D., Taylor, K.G., Cross, N.B., Kettle, A.J., Hampton, M.B., McKenzie, J.L., Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology, 137, 2012, 249.
37. Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., Weiss, S., Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J. Clin. Invest., 120, 2010, 1151.
38. Joyce, J.A., Pollard, J.W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer, 9, 2009, 239.
39. Keskinov, A.A., Shurin, M.R., Myeloid regulatory cells in tumor spreading and metastasis. Immunobiology, 220, 2015, 236.
40. Kowanetz, M., Wu, X., Lee, J., Tan, M., Hagenbeek, T., Qu, X., Yu, L., Ross, J., Korsisaari, N., Cao, T., Bou-Reslan, H., Kallop, D., Weimer, R., Ludlam, M.J., Kaminker, J.S., Modrusan, Z., van Bruggen, N., Peale, F.V., Carano, R., Meng, Y.G., Ferrara, N., Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. U. S. A., 107, 2010, 21248.
41. Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., Yu, H., Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Invest., 118, 2008, 3367.
42. Kusmartsev, S.A., Li, Y., Chen, S.H., Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol., 165, 2000, 779.
43. Liu, C.Y., Wang, Y.M., Wang, C.L., Feng, P.H., Ko, H.W., Liu, Y.H., Wu, Y.C., Chu, Y., Chung, F.T., Kuo, C.H., Lee, K.Y., Lin, S.M., Lin, H.C., Wang, C.H., Yu, C.T., Kuo, H.P., Population alterations of -arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(−)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J. Cancer Res. Clin. Oncol., 136, 2010, 35.
44. Lopez-Lago, M.A., Posner, S., Thodima, V.J., Molina, A.M., Motzer, R.J., Chaganti, R.S., Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene, 32, 2012, 1752.
45. Mabuchi, S., Matsumoto, Y., Isohashi, F., Yoshioka, Y., Ohashi, H., Morii, E., Hamasaki, T., Aozasa, K., Mutch, D.G., Kimura, T., Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol. Oncol., 122, 2011, 25.
46. Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol., 11, 2011, 519.
47. Mayadas, T.N., Cullere, X., Lowell, C.A., The multifaceted functions of neutrophils. Annu. Rev. Pathol., 9, 2014, 181.
48. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D.L., Schneck, J., Gabrilovich, D.I., Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med., 13, 2007, 828.
49. Nozawa, H., Chiu, C., Hanahan, D., Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. U. S. A., 103, 2006, 12493.
50. Ostanin, D.V., Kurmaeva, E., Furr, K., Bao, R., Hoffman, J., Berney, S., Grisham, M.B., Acquisition of antigen-presenting functions by neutrophils isolated from mice with chronic colitis. J. Immunol., 188, 2012, 1491.
51. Pekarek, L.A., Starr, B.A., Toledano, A.Y., Schreiber, H., Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med., 181, 1995, 435.
52. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V., Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol., 22, 2010, 238.
53. Pillay, J., Kamp, V.M., van Hoffen, E., Visser, T., Tak, T., Lammers, J.W., Ulfman, L.H., Leenen, L.P., Pickkers, P., Koenderman, L., A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest., 122, 2012, 327.
54. Pillay, J., Tak, T., Kamp, V.M., Koenderman, L., Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol. Life Sci., 70, 2013, 3813.
55. Qu, P., Boelte, K.C., Lin, P.C., Negative regulation of myeloid-derived suppressor cells in cancer. Immunol. Invest., 41, 2012, 562.
56. Rodriguez, P.C., Ernstoff, M.S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., Ochoa, A.C., Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res., 69, 2009, 1553.
57. Sagiv, J.Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R.V., Ariel, A., Hovav, A.H., Henke, E., Fridlender, Z.G., Granot, Z., Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep., 10, 2015, 562.
58. Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I.J., Larsen, S., Gehl, J., von der Maase, H., Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer, 93, 2005, 273.
59. Schmielau, J., Finn, O.J., Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res., 61, 2001, 4756.
60. Serafini, P., Mgebroff, S., Noonan, K., Borrello, I., Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res., 68, 2008, 5439.
61. Shoenfeld, Y., Tal, A., Berliner, S., Pinkhas, J., Leukocytosis in non hematological malignancies—a possible tumor-associated marker. J. Cancer Res. Clin. Oncol., 111, 1986, 54.
62. Sionov, R.V., Fridlender, Z.G., Granot, Z., The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 8:3 (2015), 125–158.
63. Solito, S., Marigo, I., Pinton, L., Damuzzo, V., Mandruzzato, S., Bronte, V., Myeloid-derived suppressor cell heterogeneity in human cancers. Ann. N.Y. Acad. Sci., 1319, 2014, 47.
64. Templeton, A.J., Ace, O., McNamara, M.G., Al-Mubarak, M., Vera-Badillo, F.E., Hermanns, T., Seruga, B., Ocana, A., Tannock, I.F., Amir, E., Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol. Biomarkers Prev., 23, 2014, 1204.
65. Templeton, A.J., McNamara, M.G., Seruga, B., Vera-Badillo, F.E., Aneja, P., Ocana, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J.J., Tran, B., Tannock, I.F., Amir, E., Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst., 106, 2014 dju124.
66. Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.Y., Mendrzyk, R., Hilf, N., Schoor, O., Fritsche, J., Mahr, A., Maurer, D., Vass, V., Trautwein, C., Lewandrowski, P., Flohr, C., Pohla, H., Stanczak, J.J., Bronte, V., Mandruzzato, S., Biedermann, T., Pawelec, G., Derhovanessian, E., Yamagishi, H., Miki, T., Hongo, F., Takaha, N., Hirakawa, K., Tanaka, H., Stevanovic, S., Frisch, J., Mayer-Mokler, A., Kirner, A., Rammensee, H.G., Reinhardt, C., Singh-Jasuja, H., Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med., 18, 2012, 1254.
67. Welch, D.R., Schissel, D.J., Howrey, R.P., Aeed, P.A., Tumor-elicited polymorphonuclear cells, in contrast to normal circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. U. S. A., 86, 1989, 5859.
68. Youn, J.I., Gabrilovich, D.I., The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol., 40, 2010, 2969.
69. Youn, J.I., Collazo, M., Shalova, I.N., Biswas, S.K., Gabrilovich, D.I., Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol., 91, 2012, 167.